These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 4206832

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [TSH and prolactin response to TRH in Basedow's disease].
    Gallamini A, Queirolo A, Peirano L, Barreca T.
    Boll Soc Ital Biol Sper; 1976 Dec 30; 52(24):2077-81. PubMed ID: 829560
    [No Abstract] [Full Text] [Related]

  • 7. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN, Johnson PC.
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975 Dec 30; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Graves' disease and selective resistance of pituitary thyrotroph to thyroid hormone. A case report.
    Pillay NL, Jialal I, Govender PA, Green-Thompson RW, Joubert SM.
    S Afr Med J; 1986 Sep 13; 70(6):360-1. PubMed ID: 3092372
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Proceedings: T3 suppression test and TSH and prolactin reactions to TRH in patient with Basedow's disease under treatment with thyroid antagonists].
    Ikeda H, Imai Y, Uchimura H, Yamaji T, Matsuzaki S.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):108. PubMed ID: 4141667
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apomorpine inhibits the prolactin but not the TSH response to thyrotropin releasing hormone.
    Cooper DS, Jacobs LS.
    J Clin Endocrinol Metab; 1977 Feb 20; 44(2):404-7. PubMed ID: 402381
    [Abstract] [Full Text] [Related]

  • 15. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM, Zakarija M, D'Amour P, Joasoo A.
    N Z Med J; 1975 Jan 08; 81(531):18-21. PubMed ID: 165442
    [No Abstract] [Full Text] [Related]

  • 16. [Reaction of thyrotropin and prolactin to TRH stimulation in the diagnosis of nodular thyroid gland hyperplasia].
    Vakulenko AD.
    Radiol Diagn (Berl); 1984 Jan 08; 25(5):577-81. PubMed ID: 6438695
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission.
    Dahlberg PA, Karlsson FA, Jansson R, Wide L.
    J Clin Endocrinol Metab; 1985 Dec 08; 61(6):1100-4. PubMed ID: 2414311
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone, thyrotropin, and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment.
    Carlson HE, Jacobs LS, Daughaday WH.
    J Clin Endocrinol Metab; 1973 Sep 08; 37(3):488-90. PubMed ID: 4206493
    [No Abstract] [Full Text] [Related]

  • 20. Functional relationships of the hypothalamic-pituitary-testicular system in Graves' disease.
    Földes J, Bános C, Fehér T, Bodrogi L, Szalay F, Borvendég J, Csillag J, Takó J.
    Acta Med Acad Sci Hung; 1982 Sep 08; 39(3-4):109-16. PubMed ID: 6821015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.